Globalization

ChemDiv buys Russia’s Prudentas

ChemDiv buys Russia’s Prudentas

By Gareth Macdonbald

US clinical trials firm ChemDiv has bought Russian CRO Prudentas, boosting its presence in the country at a time when the treatment naïve populations in Eastern Europe are increasingly catching the eye of the global pharma and biotech industries.

Follow us

Products

View more

Webinars